SCHEMBL14554386

SCHEMBL14554386

Cc1cc(C)c2oc3c(-c4cccc(-c5ccc6c7ccccc7c7ccccc7c6n5)c4)cc(C)cc3c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 1/20 0.36
CSNK2A2 P19784 3/20 0.36
CSNK2B P67870 3/20 0.36
CSNK2A1 P68400 3/20 0.36
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
AR P10275 2/20 0.33
PSMB5 P28074 1/20 0.33
SCN9A Q15858 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP2A6 P11509 1/20 0.31
CLK1 P49759 1/20 0.31
CLK2 P49760 1/20 0.31
DYRK1A Q13627 1/20 0.31
HIPK1 Q86Z02 1/20 0.31
DYRK2 Q92630 1/20 0.31
HIPK2 Q9H2X6 1/20 0.31
HIPK3 Q9H422 1/20 0.31
CLK4 Q9HAZ1 1/20 0.31
DYRK1B Q9Y463 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14554411 0.91 NUDT1 (0.38) NUDT1CSNK2A2CSNK2BCSNK2A1NPC1
SCHEMBL12268401 0.88 NUDT1 (0.34) NUDT1CSNK2A2CSNK2BCSNK2A1NPC1
SCHEMBL14554613 0.86 NUDT1 (0.38) NUDT1CSNK2A2CSNK2BNPC1RAB9A
SCHEMBL14554617 0.85 CRHR1 (0.36) NUDT1NPC1RAB9APSMB5SCN9A
SCHEMBL14554390 0.84 PRKDC (0.37) NPC1ARSCN9ACLK1CLK2
SCHEMBL14554584 0.84 AR (0.35) NUDT1CSNK2A2CSNK2BCSNK2A1AR
SCHEMBL11949992 0.82 CSNK2A2 (0.34) NUDT1CSNK2A2CSNK2BCSNK2A1NPC1
SCHEMBL4549385 0.82 CYP1A2 (0.41) NUDT1CSNK2A2CSNK2BCSNK2A1NPC1
SCHEMBL14554610 0.81 PRKDC (0.33) NUDT1RAB9ACLK1CLK2DYRK1A
SCHEMBL14826916 0.81 NUDT1 (0.33) NUDT1CSNK2A2CSNK2BCSNK2A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9843000-B2 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-12-12 US disclosed
US-9843000-B2 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-12-12 US disclosed
US-20160226004-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-08-04 US disclosed
US-20160226004-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-08-04 US disclosed
US-9309223-B2 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-04-12 US disclosed
US-9309223-B2 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-04-12 US disclosed
US-20140183503-A1 Light-Emitting Element, Light-Emitting Device, Electronic Appliance, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-07-03 US disclosed
US-20140183503-A1 Light-Emitting Element, Light-Emitting Device, Electronic Appliance, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-07-03 US disclosed
US-20130009543-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-01-10 US disclosed
US-20130009543-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-01-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130009543-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE NQO1, SUN2, CCNE2 NUDT1 167/4885CSNK2A2 3002/4885CSNK2B 3255/4885
US-20160226004-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE NQO1, SUN2, CCNE2 NUDT1 167/4885CSNK2A2 3002/4885CSNK2B 3255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.